Lung cancer is divided into two categories: small cell cancer and non-small cell lung cancer (NSCLC). Management of NSCLC has evolved considerably since the advent of immunotherapies and targeted therapies, both for the localized stages and for the advanced stages. NSCLC are no longer only subdivided by their histological characteristics but also by their molecular characteristics which constitute therapeutic targets.
Nathalie Baudoux, Alfredo Addeo. Non-small cell lung cancer: a target biology]. Revue medicale suisse. 2021 May 19;17(739):967-973
PMID: 34009755
View Full Text